spry1 sirna Search Results


sirnas for sprouty 1 (spry1)  (Ribobio co)
90
Ribobio co sirnas for sprouty 1 (spry1)
Sirnas For Sprouty 1 (Spry1), supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirnas for sprouty 1 (spry1)/product/Ribobio co
Average 90 stars, based on 1 article reviews
sirnas for sprouty 1 (spry1) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
small interfering rnas (sirna) for inhibiting the spry1 transcript  (Bioneer Corporation)
90
Bioneer Corporation small interfering rnas (sirna) for inhibiting the spry1 transcript
<t>SPRY1</t> is highly expressed in GBM, A. SPRY1 expression in GBM was compared using RNA-seq of REMBRANDT dataset. Data are mean ± SEM (nontumor, n = 28; astrocytoma, n = 147; oligodendroglioma, n = 67; GBM, n = 219). * **P < .001. B. SPRY1 expression compared GBM grades (Grade I and II, n = 100; Grade III, n = 85; Grade IV, n = 130). * **P < .001. C. Using microarray of REMBRANDT dataset, Kaplan-Meier survival curves of 397 GBM patients (SPRY1 high n = 185, SPRY1 low n = 212, P < .0001). D. SPRY1 expression compared IDH-mutant GBM.
Small Interfering Rnas (Sirna) For Inhibiting The Spry1 Transcript, supplied by Bioneer Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small interfering rnas (sirna) for inhibiting the spry1 transcript/product/Bioneer Corporation
Average 90 stars, based on 1 article reviews
small interfering rnas (sirna) for inhibiting the spry1 transcript - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
spry1 mouse sirna oligo duplex  (OriGene)
90
OriGene spry1 mouse sirna oligo duplex
<t>SPRY1</t> is highly expressed in GBM, A. SPRY1 expression in GBM was compared using RNA-seq of REMBRANDT dataset. Data are mean ± SEM (nontumor, n = 28; astrocytoma, n = 147; oligodendroglioma, n = 67; GBM, n = 219). * **P < .001. B. SPRY1 expression compared GBM grades (Grade I and II, n = 100; Grade III, n = 85; Grade IV, n = 130). * **P < .001. C. Using microarray of REMBRANDT dataset, Kaplan-Meier survival curves of 397 GBM patients (SPRY1 high n = 185, SPRY1 low n = 212, P < .0001). D. SPRY1 expression compared IDH-mutant GBM.
Spry1 Mouse Sirna Oligo Duplex, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spry1 mouse sirna oligo duplex/product/OriGene
Average 90 stars, based on 1 article reviews
spry1 mouse sirna oligo duplex - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
sprouty 1 (spry1) human sirna oligo duplex  (OriGene)
90
OriGene sprouty 1 (spry1) human sirna oligo duplex
<t>SPRY1</t> is highly expressed in GBM, A. SPRY1 expression in GBM was compared using RNA-seq of REMBRANDT dataset. Data are mean ± SEM (nontumor, n = 28; astrocytoma, n = 147; oligodendroglioma, n = 67; GBM, n = 219). * **P < .001. B. SPRY1 expression compared GBM grades (Grade I and II, n = 100; Grade III, n = 85; Grade IV, n = 130). * **P < .001. C. Using microarray of REMBRANDT dataset, Kaplan-Meier survival curves of 397 GBM patients (SPRY1 high n = 185, SPRY1 low n = 212, P < .0001). D. SPRY1 expression compared IDH-mutant GBM.
Sprouty 1 (Spry1) Human Sirna Oligo Duplex, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sprouty 1 (spry1) human sirna oligo duplex/product/OriGene
Average 90 stars, based on 1 article reviews
sprouty 1 (spry1) human sirna oligo duplex - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
spry1 rat sirna oligo duplex  (OriGene)
N/A
Spry1 Rat 3 unique 27mer siRNA duplexes 2 nmol each
   Buy from Supplier

Image Search Results


SPRY1 is highly expressed in GBM, A. SPRY1 expression in GBM was compared using RNA-seq of REMBRANDT dataset. Data are mean ± SEM (nontumor, n = 28; astrocytoma, n = 147; oligodendroglioma, n = 67; GBM, n = 219). * **P < .001. B. SPRY1 expression compared GBM grades (Grade I and II, n = 100; Grade III, n = 85; Grade IV, n = 130). * **P < .001. C. Using microarray of REMBRANDT dataset, Kaplan-Meier survival curves of 397 GBM patients (SPRY1 high n = 185, SPRY1 low n = 212, P < .0001). D. SPRY1 expression compared IDH-mutant GBM.

Journal: IBRO Neuroscience Reports

Article Title: Sprouty 1 is associated with stemness and cancer progression in glioblastoma

doi: 10.1016/j.ibneur.2022.07.003

Figure Lengend Snippet: SPRY1 is highly expressed in GBM, A. SPRY1 expression in GBM was compared using RNA-seq of REMBRANDT dataset. Data are mean ± SEM (nontumor, n = 28; astrocytoma, n = 147; oligodendroglioma, n = 67; GBM, n = 219). * **P < .001. B. SPRY1 expression compared GBM grades (Grade I and II, n = 100; Grade III, n = 85; Grade IV, n = 130). * **P < .001. C. Using microarray of REMBRANDT dataset, Kaplan-Meier survival curves of 397 GBM patients (SPRY1 high n = 185, SPRY1 low n = 212, P < .0001). D. SPRY1 expression compared IDH-mutant GBM.

Article Snippet: Small interfering RNAs (siRNA) for inhibiting the SPRY1 transcript, were purchased from Bioneer (Daejeon, South Korea).

Techniques: Expressing, RNA Sequencing, Microarray, Mutagenesis

SPRY1 is highly expressed in glioma cells and glioma stem cells than in normal astrocytes. A. Real-time qPCR analysis of SPRY1 mRNA expression in normal human astrocyte (NHA), glioma cells, and glioma stem cells. NHA vs. glioma cells or glioma stem cells. B and C. mRNA expression of SPRY1 , stem cell markers, and differentiation markers in NBE cultured and FBS cultured GSC11 (B) and GSC23(C). NBE vs. FBS in GSC11 and GSC23. Data are means ± SEM (n = 3). Data are means ± SEM (n = 3). *P < .05, * **P < .001, * ** *P < .0001.

Journal: IBRO Neuroscience Reports

Article Title: Sprouty 1 is associated with stemness and cancer progression in glioblastoma

doi: 10.1016/j.ibneur.2022.07.003

Figure Lengend Snippet: SPRY1 is highly expressed in glioma cells and glioma stem cells than in normal astrocytes. A. Real-time qPCR analysis of SPRY1 mRNA expression in normal human astrocyte (NHA), glioma cells, and glioma stem cells. NHA vs. glioma cells or glioma stem cells. B and C. mRNA expression of SPRY1 , stem cell markers, and differentiation markers in NBE cultured and FBS cultured GSC11 (B) and GSC23(C). NBE vs. FBS in GSC11 and GSC23. Data are means ± SEM (n = 3). Data are means ± SEM (n = 3). *P < .05, * **P < .001, * ** *P < .0001.

Article Snippet: Small interfering RNAs (siRNA) for inhibiting the SPRY1 transcript, were purchased from Bioneer (Daejeon, South Korea).

Techniques: Expressing, Cell Culture

Knockdown of SPRY1 inhibits the stemness of GSCs, A . Realtime-qPCR indicated SPRY1 knockdown efficiency using siRNA transfection in GSCs. B. Measurement of cell proliferation rate in NT (Non-targeting siRNA) and siSPRY1. *P < .05, * *P < .01. C. Effect of SPRY1 knockdown on neurosphere formation in GSC11. Data are means ± SEM (n = 3). * *P < .01. Scale bars represent 100 µm. D. Effect of SPRY1 knockdown on stem cell markers, CD15 and CD133 mRNA expression in GSC11. Data are means ± SEM (n = 3). *P < .05, * ** *P < .0001.

Journal: IBRO Neuroscience Reports

Article Title: Sprouty 1 is associated with stemness and cancer progression in glioblastoma

doi: 10.1016/j.ibneur.2022.07.003

Figure Lengend Snippet: Knockdown of SPRY1 inhibits the stemness of GSCs, A . Realtime-qPCR indicated SPRY1 knockdown efficiency using siRNA transfection in GSCs. B. Measurement of cell proliferation rate in NT (Non-targeting siRNA) and siSPRY1. *P < .05, * *P < .01. C. Effect of SPRY1 knockdown on neurosphere formation in GSC11. Data are means ± SEM (n = 3). * *P < .01. Scale bars represent 100 µm. D. Effect of SPRY1 knockdown on stem cell markers, CD15 and CD133 mRNA expression in GSC11. Data are means ± SEM (n = 3). *P < .05, * ** *P < .0001.

Article Snippet: Small interfering RNAs (siRNA) for inhibiting the SPRY1 transcript, were purchased from Bioneer (Daejeon, South Korea).

Techniques: Knockdown, Transfection, Expressing

SPRY1 positively correlates with genes associated with cancer stem cell stemness pathway. A. Upregulated genes correlated with high expression of SPRY1 analysis to Gene Ontology analysis (GO analysis) in REMBRANDT dataset. B. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis in REMBRANDT microarray dataset. C. Gene Set Enrichment Analysis (GSEA) in REMBRANDT; Representative enriched pathways in SPRY1 positive correlated samples.

Journal: IBRO Neuroscience Reports

Article Title: Sprouty 1 is associated with stemness and cancer progression in glioblastoma

doi: 10.1016/j.ibneur.2022.07.003

Figure Lengend Snippet: SPRY1 positively correlates with genes associated with cancer stem cell stemness pathway. A. Upregulated genes correlated with high expression of SPRY1 analysis to Gene Ontology analysis (GO analysis) in REMBRANDT dataset. B. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis in REMBRANDT microarray dataset. C. Gene Set Enrichment Analysis (GSEA) in REMBRANDT; Representative enriched pathways in SPRY1 positive correlated samples.

Article Snippet: Small interfering RNAs (siRNA) for inhibiting the SPRY1 transcript, were purchased from Bioneer (Daejeon, South Korea).

Techniques: Expressing, Microarray

SPRY1 correlated GBM subtype and region. A. Comparison of SPRY1 mRNA levels among the groups with GBM subtypes (Classical n = 99, Neural n = 39, Mesenchymal n = 37, Proneural n = 44) * ** P < .001. B. The graph of SPRY1 between GBM subtypes markers correlation in REMRANDT dataset. C. GSEA analysis of REMBRANDT dataset, SPRY1 positive samples correlated with GBM subtypes. D. Heatmap of SPRY1 expression signature correlated with GBM region in the Ivy GAP RNAseq dataset. CT, cellular tumor; IT, infiltration tumor; LE, leading edge; MVP, microvascular proliferation; HBV, hyperplastic blood vessels; PAN, pseudopalisading cells around necrosis; PNZ, perinecrotic zone.

Journal: IBRO Neuroscience Reports

Article Title: Sprouty 1 is associated with stemness and cancer progression in glioblastoma

doi: 10.1016/j.ibneur.2022.07.003

Figure Lengend Snippet: SPRY1 correlated GBM subtype and region. A. Comparison of SPRY1 mRNA levels among the groups with GBM subtypes (Classical n = 99, Neural n = 39, Mesenchymal n = 37, Proneural n = 44) * ** P < .001. B. The graph of SPRY1 between GBM subtypes markers correlation in REMRANDT dataset. C. GSEA analysis of REMBRANDT dataset, SPRY1 positive samples correlated with GBM subtypes. D. Heatmap of SPRY1 expression signature correlated with GBM region in the Ivy GAP RNAseq dataset. CT, cellular tumor; IT, infiltration tumor; LE, leading edge; MVP, microvascular proliferation; HBV, hyperplastic blood vessels; PAN, pseudopalisading cells around necrosis; PNZ, perinecrotic zone.

Article Snippet: Small interfering RNAs (siRNA) for inhibiting the SPRY1 transcript, were purchased from Bioneer (Daejeon, South Korea).

Techniques: Comparison, Expressing